NO20074407L - Oral doseringsform omfattende rosiglitazon - Google Patents
Oral doseringsform omfattende rosiglitazonInfo
- Publication number
- NO20074407L NO20074407L NO20074407A NO20074407A NO20074407L NO 20074407 L NO20074407 L NO 20074407L NO 20074407 A NO20074407 A NO 20074407A NO 20074407 A NO20074407 A NO 20074407A NO 20074407 L NO20074407 L NO 20074407L
- Authority
- NO
- Norway
- Prior art keywords
- dosage form
- oral dosage
- composition
- rosiglitazone
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0502475.7A GB0502475D0 (en) | 2005-02-07 | 2005-02-07 | Novel compositions |
PCT/EP2006/000997 WO2006087116A1 (fr) | 2005-02-07 | 2006-02-03 | Forme posologique orale au rosiglitazone |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20074407L true NO20074407L (no) | 2007-08-29 |
Family
ID=34355898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20074407A NO20074407L (no) | 2005-02-07 | 2007-08-29 | Oral doseringsform omfattende rosiglitazon |
Country Status (16)
Country | Link |
---|---|
US (1) | US20080166408A1 (fr) |
EP (1) | EP1855671A1 (fr) |
JP (1) | JP2008543723A (fr) |
KR (1) | KR20070110016A (fr) |
CN (1) | CN101155586A (fr) |
AU (1) | AU2006215854A1 (fr) |
BR (1) | BRPI0607803A2 (fr) |
CA (1) | CA2595411A1 (fr) |
EA (1) | EA200701681A1 (fr) |
GB (1) | GB0502475D0 (fr) |
IL (1) | IL184790A0 (fr) |
MA (1) | MA29281B1 (fr) |
MX (1) | MX2007009492A (fr) |
NO (1) | NO20074407L (fr) |
TW (1) | TW200700063A (fr) |
WO (1) | WO2006087116A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0203296D0 (en) * | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
US8637512B2 (en) * | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
EP1967182A1 (fr) * | 2007-03-07 | 2008-09-10 | KRKA, tovarna zdravil, d.d., Novo mesto | Composition pharmaceutique comprenant un sel de rosiglitazone |
US20100323015A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
US20100323016A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
US20100120906A1 (en) * | 2008-07-18 | 2010-05-13 | Valeant Pharmaceuticals International | Modified release formulation and methods of use |
EP2787971A4 (fr) | 2012-02-22 | 2015-04-29 | Duchesnay Inc | Formulation de doxylamine et de pyridoxine et/ou de leurs métabolites ou sels |
MX366760B (es) | 2013-07-22 | 2019-07-23 | Duchesnay Inc | Composición para la gestión de las náuseas y los vómitos. |
US9452181B2 (en) | 2013-07-22 | 2016-09-27 | Duchesnay Inc. | Composition for the management of nausea and vomiting |
TWI595874B (zh) | 2014-08-29 | 2017-08-21 | 達契斯奈股份有限公司 | 多西拉敏及吡哆醇及/或其代謝產物或鹽之多模式釋放調配物 |
CA3077514C (fr) * | 2017-10-25 | 2022-10-11 | Chiesi Farmaceutici S.P.A. | Comprimes de deferiprone a liberation retardee et procedes d'utilisation correspondants |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5407687A (en) * | 1994-02-22 | 1995-04-18 | Glaxo Inc. | Ranitidine solid dosage form |
WO2000028989A1 (fr) * | 1998-11-12 | 2000-05-25 | Smithkline Beecham P.L.C. | Composition pharmaceutique a liberation modifiee d'un agent de sensibilisation a l'insuline, et d'un autre agent antidiabetique |
UY28457A1 (es) * | 2003-08-07 | 2005-03-31 | Sb Pharmco Inc | Nueva composición |
EP1732513A2 (fr) * | 2003-12-31 | 2006-12-20 | Alpharma, Inc. | Preparations de rosiglitazone |
-
2005
- 2005-02-07 GB GBGB0502475.7A patent/GB0502475D0/en not_active Ceased
-
2006
- 2006-02-03 AU AU2006215854A patent/AU2006215854A1/en not_active Abandoned
- 2006-02-03 KR KR1020077018029A patent/KR20070110016A/ko not_active Application Discontinuation
- 2006-02-03 CN CNA2006800111173A patent/CN101155586A/zh active Pending
- 2006-02-03 MX MX2007009492A patent/MX2007009492A/es not_active Application Discontinuation
- 2006-02-03 CA CA002595411A patent/CA2595411A1/fr not_active Abandoned
- 2006-02-03 EA EA200701681A patent/EA200701681A1/ru unknown
- 2006-02-03 US US11/815,326 patent/US20080166408A1/en not_active Abandoned
- 2006-02-03 JP JP2007553549A patent/JP2008543723A/ja not_active Withdrawn
- 2006-02-03 EP EP06742510A patent/EP1855671A1/fr not_active Withdrawn
- 2006-02-03 WO PCT/EP2006/000997 patent/WO2006087116A1/fr active Application Filing
- 2006-02-03 BR BRPI0607803-6A patent/BRPI0607803A2/pt not_active IP Right Cessation
- 2006-02-06 TW TW095103942A patent/TW200700063A/zh unknown
-
2007
- 2007-07-23 IL IL184790A patent/IL184790A0/en unknown
- 2007-08-29 NO NO20074407A patent/NO20074407L/no not_active Application Discontinuation
- 2007-08-31 MA MA30182A patent/MA29281B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006087116A1 (fr) | 2006-08-24 |
CN101155586A (zh) | 2008-04-02 |
BRPI0607803A2 (pt) | 2009-06-13 |
GB0502475D0 (en) | 2005-03-16 |
AU2006215854A1 (en) | 2006-08-24 |
KR20070110016A (ko) | 2007-11-15 |
EA200701681A1 (ru) | 2007-12-28 |
US20080166408A1 (en) | 2008-07-10 |
CA2595411A1 (fr) | 2006-08-24 |
JP2008543723A (ja) | 2008-12-04 |
EP1855671A1 (fr) | 2007-11-21 |
MX2007009492A (es) | 2007-09-19 |
MA29281B1 (fr) | 2008-02-01 |
IL184790A0 (en) | 2007-12-03 |
TW200700063A (en) | 2007-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074407L (no) | Oral doseringsform omfattende rosiglitazon | |
EA200701680A1 (ru) | Лекарственная форма для перорального введения, содержащая розиглитазон | |
HUP0301161A2 (hu) | Az 5-[4-[2-[N-metil-N-(2-piridil)-amino]-etoxi]-benzil]-tiazolidin-2,4-dion-maleát új polimorf formái és eljárás azok előállítására | |
EA200702648A1 (ru) | Фармацевтическая композиция, пригодная для введения один раз в день | |
AR045330A1 (es) | Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla | |
US20070010553A1 (en) | New use | |
YU16303A (sh) | Tartaratne soli derivata tiazolidindiona | |
DK1349855T3 (da) | 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt | |
AP1715A (en) | The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione | |
DE60212434D1 (de) | Rosiglitazon-edisylate und ihre verwendung als antidiabetika | |
NO20076517L (no) | Natriumsalter av 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksyl]benzyl]tiazolidin-2,4-dion | |
CY1107421T1 (el) | Τρυγικα αλατα παραγωγου θειαζολιδινοδιονης | |
NO20075507L (no) | Tiazolidindionderivater og deres anvendelse som antidiabetiske midler | |
AP1785A (en) | Tartrate salt of thiazolidinedione derivative. | |
RS50130B (sr) | Farmaceutska kompozicija 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil) tiazolidin-2,4-diona | |
AP2002002673A0 (en) | Thiazolidinedione salt for the treatment of diabetes mellitus. | |
AP2003002737A0 (en) | Tartrate salts of thiazolidinedione derivatives | |
AP2002002684A0 (en) | 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical | |
JP2006528206A5 (fr) | ||
BRPI0607804A2 (pt) | braçadeira de lámina despeladora com ranhuras de saìda de gordura | |
Weber et al. | In vitro studies and computer simulation of interactions between R483, a novel thiazolidinedione, and cytochrome P450 substrates | |
TH84984B (th) | รูปแบบของการให้ยาทางปากซึ่งประกอบด้วย5-[4-[2-(n-เมธิล-n-(2-ไพริดิล)อะมิโน)เอธอกซี]เบนซิล]ไธอะโซลิดีน-2,4-ไดโอน | |
DK1448559T3 (da) | 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |